| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |